Aquigen Bio Sciences Pioneers Sustainable Biotech Solutions Amid Rising Global Demand and Critical Supply Chain Needs

August 04, 2025 – Pune, India – Aquigen Bio Sciences is proud to be a pioneer in a new era of sustainable biotechnology, designed to meet the increasing global demand for advanced scientific solutions while strengthening critical pharmaceutical and industrial supply chains. As a leading Contract Research Organization, Aquigen Bio Sciences continues to set industry standards with its commitment to innovation, reliability, and safety across the biotechnology landscape.

“Our mission has alays been to empoer researchers and innovators across the globe. By focusing on sustainable practices and scientific rigor, Aquigen Bio Sciences delivers solutions our clients can truly trust. From API & Intermediates to the most advanced impurity standards and custom synthesis projects, our passionate team is dedicated to pioneering innovation hile maintaining the highest ethical and quality benchmarks,” said the CEO of Aquigen Bio Sciences, emphasizing the company’s unwavering commitment to scientific excellence, global compliance, and the long-term well-being of patients and the planet.

Innovation and Excellence in API & Intermediates

Aquigen Bio Impurity supplier and manufacturer is uniquely positioned to assist pharmaceutical, biological, nutraceutical, and cosmetic industries by designing and optimizing synthetic routes for research-grade molecules. The company’s dedication to quality and safety can be seen in its robust catalogue of API & Intermediates, each produced to the highest standards to support drug discovery and development pipelines globally. With a focus on efficiency, scalability, and regulatory alignment, Aquigen ensures its offerings remain reliable across every stage of R&D. Backed by a team of experienced chemists and modern infrastructure, the company continues to push the boundaries of innovation in complex synthesis.

Comprehensive Impurity Standards Portfolio

Recognizing the growing need for precise and traceable impurity profiling, Aquigen Bio Sciences offers a world-class suite of impurity standards, from degradation and process impurities to medicinal chemistry molecules and building blocks. The company’s impurity standards are essential for accurate method development and regulatory compliance.

Specialty Product Focus:

  • Includes nitrosamines such as NDMA, NDEA, NMBA, which are strictly controlled, precisely characterized and designed to support analytical excellence.

Trusted Supplier of Nicotine Impurity Standards:

Quality & Characterization:

  • All reference materials are developed under rigorous quality systems
  • Supplied with comprehensive characterization data to ensure consistency and reliability

Leadership in Custom Synthesis and Deuterated Labelled Compounds

Aquigen Bio Sciences is not only a supplier of off-the-shelf standards but also an industry leader in custom synthesis. With a team of highly experienced synthetic chemists, the company can design and develop bespoke molecules and intermediates tailored to client specifications. This ability enables the rapid acceleration of clients’ research programs.

In addition, Aquigen Bio Sciences has expanded its capabilities in deuterated labelled compounds, which are critical for advanced pharmacokinetic studies and other applications demanding isotopically labeled materials.

Addressing Global Challenges and Ensuring Sourcing Reliability

Supply Chain Resilience: The pandemic revealed critical vulnerabilities in global pharmaceutical supply chains. Aquigen Bio Sciences is addressing these by improving transparency, sustainability, and responsiveness. This ensures clients receive dependable access to hard-to-find reference standards and novel impurity classes.

Support for Complex Molecules: Aquigen offers high-purity reference standards for complex molecules like Lenacapavir and its impurities, aiding development of advanced antiviral agents through robust analytical tools.

Agile Innovation Pipeline: The company’s flexible development capabilities allow for rapid response to new regulatory requirements and emerging therapeutic trends

Technical Capabilities & Infrastructure

  • A 17,000 ft. advanced manufacturing facility in Pune, equipped to handle production at scales ranging from milligrams to kilograms.
  • A dedicated R&D center featuring high-tech laboratories and a team of 50+ scientists, backed by robust QC teams and cutting-edge analytical tools including HPLC, NMR, and
  • Expertise in synthesizing impurities, genotoxic nitrosamines, degradation products, deuterated isotopes, peptides, and intermediates.

Why Aquigen Bio Sciences Matters?

  • Regulatory-ready: Compliant with compendial and ICH Q3A/B standards, with CoA (HPLC, NMR, MS) included.
  • Fast & flexible: Custom synthesis for rare impurities with quick
  • Global reach: Serving 25 + countries across pharma, biotech, labs, and

The Way Forward:

Aquigen Bio Sciences is poised to lead the next chapter in impurity standards and sustainable biotechnology, and is trusted across India and beyond for its expertise. The company continues to drive innovation through custom solutions and research-centric development. As global demand for responsible, high-quality biotech solutions accelerates, Aquigen Bio Sciences remains committed to empowering pharmaceutical and industrial progress, paving the way for a safer, healthier, and more sustainable future.

Explore Aquigen Bio Sciences’ comprehensive range of products, including nitrosamine impurity, Nicotine impurity, and Lenacapavir impurity standards

Contact:
Aquigen Bio Sciences Pvt Ltd
Pune, Maharashtra 412108
Phone: +91 7030123794
Email: bd@aquigenbio.com
Visit: www.aquigenbio.com

You May Also Like